Clinical trial

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

NCT00995241

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Raltegravir Normalized identity: raltegravirView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-11-01

PhasePHASE4

Conditions

HIV Infectionsunresolved

Interventions

RaltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

Germans Trias i Pujol Hospitallead sponsor

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Cienciacollaborator

Mapped research locations

BarcelonaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00995241 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.